Anne-Marie Duliege

2019

In 2019, Anne-Marie Duliege earned a total compensation of $1.6M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals, a 6% decrease compared to previous year.

Compensation breakdown

Option Awards$420,682
Salary$309,783
Other$869,544
Total$1,600,010

Duliege received $869.5K in other compensation, accounting for 54% of the total pay in 2019.

Duliege also received $420.7K in option awards and $309.8K in salary.

Rankings

In 2019, Anne-Marie Duliege's compensation ranked 7,020th out of 13,971 executives tracked by ExecPay. In other words, Duliege earned more than 49.8% of executives.

ClassificationRankingPercentile
All
7,020
out of 13,971
50th
Division
Manufacturing
2,689
out of 5,695
53rd
Major group
Chemicals And Allied Products
988
out of 2,194
55th
Industry group
Drugs
837
out of 1,880
56th
Industry
Pharmaceutical Preparations
615
out of 1,392
56th
Source: SEC filing on April 1, 2020.

Duliege's colleagues

We found six more compensation records of executives who worked with Anne-Marie Duliege at Rigel Pharmaceuticals in 2019.

2019

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2019

Dolly Vance

Rigel Pharmaceuticals

Executive Vice President, Corporate Affairs, General

2019

Dean Schorno

Rigel Pharmaceuticals

Chief Financial Officer

2019

Eldon Mayer

Rigel Pharmaceuticals

Executive Vice President, Chief Commercial Officer

2019

Esteban Masuda

Rigel Pharmaceuticals

Executive Vice President, Research

2019

Wolfgang Dummer

Rigel Pharmaceuticals

Chief Medical Officer

News

You may also like